Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

207713

Sigma-Aldrich

1,3-Di-o-tolylguanidine

99%

Synonym(s):

DTG

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
(CH3C6H4NH)2C(=NH)
CAS Number:
97-39-2
Molecular Weight:
239.32
EC Number:
202-577-6
MDL number:
MFCD00008513
UNSPSC Code:
12352100
PubChem Substance ID:
24852467
NACRES:
NA.22

Assay

99%

form

solid

mp

176-178 °C (lit.)

solubility

water: soluble 70 mg/mL at 20 °C

SMILES string

Cc1ccccc1NC(=N)Nc2ccccc2C

InChI

1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18)

InChI key

OPNUROKCUBTKLF-UHFFFAOYSA-N

Gene Information

human ... EBP(10682)

Looking for similar products? Visit Product Comparison Guide

General description

1,3-Di-o-tolylguanidine is a selective σ-receptor agonist. 1,3-Di-o-tolylguanidine is σ site ligand and its interaction with dopamine drugs were studied in Wistar rats and Albino Swiss mice.

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

J Maj et al.
Polish journal of pharmacology, 48(4), 379-395 (1996-07-01)
1,3-Di-o-tolylguanidine (DTG), opipramol (OPI) and sertraline (SER), sigma site ligands, were studied in Wistar rats and Albino Swiss mice, mainly with regard to their interaction with dopamine drugs. DTG and SER (at the highest doses only) decreased the spontaneous locomotor
Grzegorz Wicher et al.
Journal of neurotrauma, 34(22), 3173-3182 (2017-05-12)
Traumatic brain injury (TBI) is a devastating condition, often leading to life-long consequences for patients. Even though modern neurointensive care has improved functional and cognitive outcomes, efficient pharmacological therapies are still lacking. Targeting peripherally derived, or resident inflammatory, cells that
Martina Kovarova et al.
Nature communications, 9(1), 4156-4156 (2018-10-10)
Non-adherence to medication is an important health care problem, especially in the treatment of chronic conditions. Injectable long-acting (LA) formulations of antiretrovirals (ARVs) represent a viable alternative to improve adherence to HIV/AIDS treatment and prevention. However, the LA-ARV formulations currently
Jiping Liu et al.
Polymers, 11(5) (2019-05-16)
Modified nano-TiO2 was prepared by using triethanolamine and tetraisopropyl di (dioctylphosphate) titanate, respectively. Then the poly(p-phenylene benzobisoxazole) (PBO) fibers doped with different additions of modified nano-TiO2 particles were prepared by preparing PBO polymer solution and dry-jet wet spinning technique. Thermogravimetric
Zur Mira Azizah Nor Haiza Lah et al.
Journal of pharmaceutical and biomedical analysis, 174, 608-617 (2019-07-03)
A facile electrochemical sandwich immunosensor for the detection of a breast cancer biomarker, the human epidermal growth factor receptor 2 (HER2), was designed, using lead sulfide quantum dots-conjugated secondary HER2 antibody (Ab2-PbS QDs) as a label. Using Ab2-PbS QDs in
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service